EX-99 2 bdsiex99-061809.htm JUNE 18, 2009

EXHIBIT 1(a)

Trades on June 17, 2009

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.   Title of Security
(Instr. 3)

2. Transaction Date

2A.Deemed Execution Date, if any

3. Transaction Code (Instr. 8)

  4.   Securities Acquired (A) or Disposed of (D)

(Instr. 3, 4 and 5)

5. Amount of
Securities Beneficially
Owned Following

6. Ownership Form: Direct (D)

or

7. Nature of Indirect Beneficial Ownership

 

 

(Month/
Day/
Year)

(Month/
Day/
Year)

 

Code

 

V

 

Amount

(A)or (D)

 

Price

 

Reported
Transaction(s)

(Instr. 3 and 4)

Indirect (I)

(Instr. 4)

 

(Instr. 4)

Common Stock

06/17/09

 

S

 

69,064

D

6.3500

1,325,936

I

(1)

Common Stock

06/17/09

 

S

 

1,600

D

6.3600

1,324,336

I

(1)

Common Stock

06/17/09

 

S

 

9,825

D

6.4000

1,314,511

I

(1)

Common Stock

06/17/09

 

S

 

1,500

D

6.4300

1,313,011

I

(1)

Common Stock

06/17/09

 

S

 

100

D

6.4400

1,312,911

I

(1)

Common Stock

06/17/09

 

S

 

16,511

D

6.600

1,296,400

I

(1)

Common Stock

06/17/09

 

S

 

1,400

D

6.6500

1,295,000

I

(1)

 

 

EXHIBIT 1(b)

Trades on June 18, 2009

Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.   Title of Security
(Instr. 3)

2. Transaction Date

2A.Deemed
Execution Date, if any

3. Transac-tion Code (Instr. 8)

4.   Securities Acquired (A) or Disposed of (D)

(Instr. 3, 4 and 5)

5. Amount of
Securities Beneficially
Owned Following

6. Ownership Form: Direct (D) or

 

7. Nature of Indirect Beneficial Ownership

 

 

(Month/
Day/
Year)

(Month/
Day/
Year)

 

Code

 

V

 

Amount

(A)or (D)

 

Price

 

Reported
Transaction(s)

(Instr. 3 and 4)

Indirect (I)

(Instr. 4)

 

(Instr. 4)

Common Stock

06/18/09

 

S

 

15,191

D

6.4000

1,279,809

I

(1)

Common Stock

06/18/09

 

S

 

2,800

D

6.4100

1,277,009

I

(1)

Common Stock

06/18/09

 

S

 

500

D

6.4200

1,276,509

I

(1)

Common Stock

06/18/09

 

S

 

25,000

D

6.5000

1,251,509

I

(1)

Common Stock

06/18/09

 

S

 

19,900

D

6.6000

1,231,609

I

(1)

 

(1) Elliott Associates, L.P., through its subsidiary, Manchester Securities Corp., a New York corporation (“Manchester”), has an indirect pecuniary interest in the shares of common stock of BioDelivery Sciences International, Inc. (“BDSI”), owned by CDC IV, LLC (“CDC IV”). Manchester owns a majority of the equity interest of CDC IV (but not a controlling interest). On June 4, 2009, the manager of CDC IV delegated to Manchester all of the manager’s rights and authority with respect to the investment decisions relating to the equity securities of BDSI owned by CDC IV.